• 1
    Robinson, D. S., Hamid, Q., Bentley, A. M., Ying, S., Kay, A. B., Durham, S. R. and Kay, A. B., Activation of CD4+ T cells, increased Th2-type mRNA expression and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J. Allergy Clin. Immunol. 1993. 92: 313324.
  • 2
    Robinson, D. S., Hamid, Q., Ying, S., Tsicopoulos, A., Barkans, J., Bentley, A. M., Corrigan, C., Durham, S. R. and Kay, A. B., Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 1992. 326: 298304.
  • 3
    Tang, C., Rolland, J. M., Ward, C., Quan, B. and Waters, E. H., IL-5 production by bronchoalveolar lavage and peripheral blood mononuclear cells in asthma and atopy. Eur. Respir. J. 1997. 10: 624632.
  • 4
    Holgate, S. T., The epidemic of allergy and asthma. Nature 1999. 402 (6760 Suppl): B2B4.
  • 5
    Herrick, C. A. and Bottomly, K., To respond or not to respond: T cells in allergic asthma. Nat. Rev. Immunol. 2003. 3: 405412.
  • 6
    Elias, J. A, Lee, C. G., Zheng, B., Homer, R. J. and Zhu, Z., New insights into the pathogenesis of asthma. J. Clin. Invest. 2003. 111: 291297.
  • 7
    Akbari, O., Stock, P., Meyer, E., Kronenberg, M., Sidobre, S., Nakayama, T., Taniguchi, M., Grusby, M. J., DeKruyff, R. H. and Umetsu, D. T., Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat. Med. 2003. 9: 582588.
  • 8
    Korsgren, M., Persson, C. G., Sundler, F., Bjerke, T., Hansson, T., Chambers, B. J., Hong, S., Van Kaer, L., Ljunggren, H. G. and Korsgren, O., Natural killer cells determine development of allergen-induced eosinophilic airway inflammation in mice. J. Exp. Med. 1999. 189: 553562.
  • 9
    Neurath, M. F., Finotto S. and Glimcher, L. H., The role of Th1/Th2 polarization in mucosal immunity. Nat. Med. 2002. 8: 567573.
  • 10
    Szabo, S. J., Sullivan, B. M., Peng, S. L. and Glimcher, L. H., Molecular mechanisms regulating Th1 immune responses. Annu. Rev. Immunol. 2003. 21: 713758.
  • 11
    Myou, S., Leff, A. R., Myo, S., Boetticher, E., Tong, J., Meliton, A. Y., Liu, J., Munoz, X. and Zhu, X., Blockade of inflammation and airway hyperresponsiveness in immune-sensitized mice by dominant-negative phosphoinositide 3-kinase-TAT. J. Exp. Med. 2003. 17: 198: 1573–1582.
  • 12
    Finotto, S., De Sanctis, G. T., Lehr, H. A., Herz, U., Buerke, M., Schipp, M., Bartsch, B., Atreya, R., Schmitt, E., Galle, P. R., Renz, H. and Neurath, M. F., Treatment of allergic airway inflammation and hyperresponsiveness by antisense-induced local blockade of GATA-3 expression. J. Exp. Med. 2001. 193: 12471260.
  • 13
    Zhang, D. H., Yang, L., Cohn, L., Parkyn, L., Homer, R., Ray, P. and Ray, A., Inhibition of allergic inflammation in a murine model of asthma by expression of a dominant-negative mutant of GATA-3. Immunity 1999. 11: 473482.
  • 14
    Das, J., Chen, C. H., Yang, L., Cohn, L., Ray, P. and Ray, A., A critical role for NF-kappa B in GATA3 expression and TH2 differentiation in allergic airway inflammation. Nat. Immunol. 2001. 2: 4550.
  • 15
    Ho, I. C., Hodge, M. R., Rooney, J. W. and Glimcher, L. H., The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell 1996. 85: 973983.
  • 16
    Ho, I. C., Lo, D. and Glimcher, L. H., c-maf promotes T-helper cell type 2 (TH2) and attenuates TH1 differentiation by both interleukin 4-dependent and -independent mechanisms. J. Exp. Med. 1998. 188: 18591866.
  • 17
    Kim, J. I., Hamid, Q., Ying, S. and Glimcher, L. H., The transcription factor c-Maf controls the production of interleukin-4 but not other Th2 cytokines. Immunity 1999. 10: 745751.
  • 18
    Kerppola, T. K. and Curran, T., Maf and nrl can bind to AP-1 sites and form heterodimers with fos and jun. Oncogene 1994. 9: 675684.
  • 19
    Kataoka, K., Noda, M. and Nishizawa, M., Maf nuclear oncoprotein recognizes sequences related to an AP-1 site and forms heterodimers with both fos and jun. Mol. Cell. Biol. 1994. 14: 700712.
  • 20
    Kataoka, K., Nishizawa, M. and Kawai, S., Structure-function analysis of the maf oncogene product, a member of the b-zip protein family. J. Virol. 1993. 67: 21332141.
  • 21
    Taha, R., Hamid, Q., Cameron, L. and Olivenstein, R., T helper type 2 cytokine receptors and associated transcription factors GATA-3, c-maf, and signal transducer and activator of transcription factor-6 in induced sputum of atopic asthmatic patients. Chest 2003. 123: 20742082.
  • 22
    Erpenbeck, V. J., Hohlfeld, J. M., Discher, M., Krentel, H., Hagenberg, A., Braun, A. and Krug, N., Increased messenger RNA expression of c-maf and GATA-3 after segmental allergen challenge in allergic asthmatics. Chest 2003. 123: 370S–371S.
  • 23
    Gorska, M. M. and Alam, R., Signaling molecules as therapeutic targets in allergic diseases. J. Allergy Clin. Immunol. 2003. 112: 241250.
  • 24
    Wills-Karp, M., Luyimbazi, J., Xu, X., Schofield, B., Neben, T. Y., Karp, C. L. and Donaldson, D. D., Interleukin-13: central mediator of allergic asthma. Science 1998. 282: 22582261.
  • 25
    Zheng, T., Zhu, Z., Liu, W., Lee, C. G., Chen, Q., Homer, R. J. and Elias, J. A., Cytokine regulation of IL-13Ralpha2 and IL-13Ralpha1 in vivo and in vitro. J. Allergy Clin. Immunol. 2003. 111: 720728.
  • 26
    Hofmann, A., Nolan, G. P. and Blau, H. M., Rapid retroviral delivery of tetracycline-inducible genes in a single autoregulatory cassette. Proc. Natl. Acad. Sci. USA 1996. 93: 51855190.
  • 27
    Foster, P. S., Ming, Y., Matthei, K. I., Young, I. G., Temelkovski, J. and Kumar, R. K., Dissociation of inflammatory and epithelial responses in a murine model of chronic asthma. Lab. Invest. 2000. 80: 655662.
  • 28
    Kuperman, D. A., Huang, X., Koth, L. L., Chang, G. H.,. Dolgano, G. M., Zhu, Z., Elias, J. A., Sheppard, D. and Erle, D. J., Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat. Med. 2002. 8: 885889.
  • 29
    Hirst, S. J., Hallsworth, M. P., Peng, Q. and Lee, T., Selective induction of eotaxin release by interleukin-13 or interleukin-4 in human airway smooth muscle cells is synergistic with interleukin-1beta and is mediated by the interleukin-4 receptor alpha-chain. Am. J. Respir. Crit. Care Med. 2002. 15: 11611171.
  • 30
    Izuhara, K., Arima, K. and Yasunaga, S., IL-4 and IL-13: their pathological roles in allergic diseases and their potential in developing new therapies. Curr. Drug Targets Inflamm. Allergy 2002. 1: 263269.
  • 31
    Taube, C., Duez, C., Cui, Z. H., Takeda, K., Rha, Y. H., Park, J. W., Balhorn, A., Donaldson, D. D., Dakhama, A. and Gelfand, E. W., The role of IL-13 in established allergic airway disease. J. Immunol. 2002. 169: 64826489.
  • 32
    Kelly-Welch, A. E., Hanson, E. M., Boothby, M. R. and Keegan, A. D., Interleukin-4 and interleukin-13 signaling connections maps. Science 2003. 300: 15271528.
  • 33
    Kaplan, M. H., Schindler, U., Smiley, S. T. and Grusby, N. J., Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 2001. 4: 313319.
  • 34
    Demoulin, J. B. and Renauld, J. C., Signalling by cytokines interacting with the interleukin-2 receptor gamma chain. Cytokines Cell Mol. Ther. 1998. 4: 243256.
  • 35
    Wills-Karp, M. and Chiaramonte, M., Interleukin-13 in asthma. Curr. Opin. Pulm. Med. 2003. 9: 2127.
  • 36
    Kishikawa, H., Sun, J., Choi, A., Miaw, S. C. and Ho, I. C., The cell type-specific expression of the murine IL-13 gene is regulated by GATA-3. J. Immunol. 2001. 167: 44144420.
  • 37
    Thornton, A. M., Piccirillo, C. A. and Shevach, E. M., Activation requirements for the induction of CD4+CD25+ T cell suppressor function. Eur. J. Immunol. 2004. 34: 366376.
  • 38
    Finotto, S., Neurath, M. F., Glickman, J. N., Qin, S., Lehr, H. A., Green, F. H., Ackerman, K., Haley, K., Galle, P. R., Szabo, S. J., Drazen, J. M., De Sanctis, G. T. and Glimcher, L. H., Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet. Science 2002. 295: 336338.